GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HBM Holdings Ltd (HKSE:02142) » Definitions » Receipts from Customers

HBM Holdings (HKSE:02142) Receipts from Customers


View and export this data going back to 2020. Start your Free Trial

What is HBM Holdings Receipts from Customers?

Receipts from Customers only applicable to companies reporting Cash Flow from Operations in direct method.


HBM Holdings Business Description

Traded in Other Exchanges
Address
218 Xinghu Street, Suite 202, Building A3, Suzhou Industrial Park, Suzhou, CHN, 215123
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. The majority of the revenue for the firm is generated from the United States.
Executives
Wang Jingsong 2101 Beneficial owner
Gic Private Limited 2102 Investment manager
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you
Owap Investment Pte Ltd 2101 Beneficial owner
Gic Special Investments Private Limited 2102 Investment manager
Gic (ventures) Pte. Ltd. 2201 Interest of corporation controlled by you
South Dakota Trust Company Llc 2301 Trustee
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Pang Kee Chan Hebert
Morgan Stanley Investments (uk) 2201 Interest of corporation controlled by you
Morgan Stanley International Limited 2201 Interest of corporation controlled by you
Morgan Stanley International Holdings Inc. 2201 Interest of corporation controlled by you
Morgan Stanley & Co. International Plc 2105 Underwriter
Advantech Capital Holdings Ltd.
Harbourbio Llc 2101 Beneficial owner